RecruitingNot ApplicableNCT05857995

Precision Lung Cancer Survivorship Care Intervention

Precision Lung Cancer Survivorship Care Intervention: A Randomized Controlled Trial Serving Rural Survivors and Communities

Sponsor

Jerod L Stapleton, PhD

Enrollment

300 participants

Start Date

Aug 16, 2024

Study Type

INTERVENTIONAL

Conditions

Lung Cancers Lung Cancer Cancer, Lung Cancer of the Lung Pulmonary Cancer Pulmonary Neoplasm Neoplasms, Lung Neoplasms, Pulmonary Neoplasm, Pulmonary Cancers, Lung Cancer, Pulmonary Cancers, Pulmonary Pulmonary Cancers Cancer of Lung Pulmonary Neoplasms

Summary

The overarching goal of the Kentucky LEADS Collaborative Lung Cancer Survivorship Care program is to reduce the burden of lung cancer by offering an innovative survivorship care approach that improves lung cancer quality of life, overcomes lung cancer stigma, and helps survivors engage with care. The project involves a two-group parallel randomized clinical trial comparing the impact of the Kentucky LEADS Collaborative Lung Cancer Survivorship Care program (KLCLCSC) among lung cancer survivors (N=300) against an enhanced usual care condition (bibliotherapy+assessment) on quality of life outcomes.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a personalized survivorship care program for people with lung cancer who live in rural areas — offering individualized support, health monitoring, and resources after treatment to improve quality of life and long-term health outcomes. **You may be eligible if...** - You have been diagnosed with lung cancer - You live in a rural county (based on Rural Urban Continuum Code of 4 or higher) - You are 18 or older and can communicate effectively in English **You may NOT be eligible if...** - You have significant psychiatric or substance use conditions that require a higher level of care - You are currently enrolled in another lung cancer survivorship care program - You have previously participated in the Kentucky LEADS Lung Cancer Survivorship Care Program Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALKentucky LEADS Collaborative Lung Cancer Survivorship Care Program

KLCLCSC is a survivor or survivor plus caregiver-focused psychosocial and behavioral intervention designed to engage lung cancer survivors and improve lung cancer outcomes.

BEHAVIORALEnhanced Usual Care

EUC involves a combination of the standard of care plus a bibliotherapy intervention and assessment.

Locations(1)

Markey Cancer Center

Lexington, Kentucky, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05857995

Related Trials

Standard Follow-up Program (SFP) for Lung Cancer Patients Treated With Radiotherapy or Chemoradiation

NCT024217181 location

Molecular Analysis of Endoscopic Cytology Samples Supernatant in Pulmonary Nodules

NCT053069121 location

Metabolic Biomarkers in Thoracic Cancers

NCT020958081 location

Safety and Efficacy of OBX-115 in Advanced Solid Tumors

NCT060606139 locations

Spatially Fractionated Radiotherapy Combined With Immunotherapy for Advanced Solid Tumors

NCT070589483 locations